Members

Resource library

Our regulatory position papers and whitepapers on digital health technologies in clinical trials. Three download without an account; a free account opens the rest after email confirmation and personal approval, usually within one business day. No sales calls attached.

7 papers tagged “ICH E6(R3)”
Quality & Regulatory Assurance — service brochure qointa Services brochures Free 2 pages

Quality & Regulatory Assurance — service brochure

Quality and regulatory assurance — QMS design, regulatory strategy and ongoing compliance support for life-science organisations.

Download PDF →
DeviceFit — fit-for-purpose validation Device360 Brochures Free 2 pages

DeviceFit — fit-for-purpose validation

Technical, clinical and operational validation aligned to ISO 14971, IEC 62366-1, FDA QSR, EU MDR Annex I and ICH-GCP.

Download PDF →
The Sponsor’s Accountability Map Position papers Free 6 pages

The Sponsor’s Accountability Map

A companion reading from the sponsor’s seat — what you can delegate the work of, and what you answer for regardless

Read the summary →
You Can Delegate the Work, Not the Accountability: Vendor Qualification and Oversight under ICH E6(R3) Position papers 9 pages

You Can Delegate the Work, Not the Accountability: Vendor Qualification and Oversight under ICH E6(R3)

The sponsor’s duty to qualify and oversee its DHT vendors — distinct from who holds the economic-operator role.

Read the summary →
QMS Integration: Embedding DHT Controls across Sponsor and Vendor Quality Systems Position papers 9 pages

QMS Integration: Embedding DHT Controls across Sponsor and Vendor Quality Systems

Why the seam between GCP, ISO 13485 and software-lifecycle quality systems is where DHT control is won or lost.

Read the summary →
Consent on a Screen: The Regulatory Anatomy of eConsent Position papers 9 pages

Consent on a Screen: The Regulatory Anatomy of eConsent

Why electronic informed consent sits across electronic signature, data protection and GCP / ethics — all at once — and why acceptance is not universal.

Read the summary →
ALCOA+ on the Device: Device-Side Data Integrity in GCP Position papers 8 pages

ALCOA+ on the Device: Device-Side Data Integrity in GCP

When a device captures trial data — a handset, a wearable, a home instrument or the gateway that relays them — attribution, time and protection against alteration are decided on the device, and no validated database can decide them later.

Read the summary →

A paper raised a question about your study?

The people who wrote these papers run the assessments. Bring the device and the protocol; fifteen minutes is enough to know whether it matters for your trial.

Book a 15-minute call